ライフサイエンスコーパス: gonadotrophin

1 xyprogesterone in response to stimulation by gonadotrophin.

2 natal testicular development is dependent on gonadotrophin and androgen stimulation.

3 n of differentiation markers human chorionic gonadotrophin and placental alkaline phosphatase was una

4 em gene expression depended on androgens and gonadotrophins, as demonstrated by a lack of expression

5 Human chorionic gonadotrophin beta (beta-hCG) and progesterone concentra

6 (i.e., her offspring's) homologous chorionic gonadotrophin beta5 (CGB5) and CSH1 genes and her post-p

7 modulation of uterine function by chorionic gonadotrophin (CG) in a nonhuman primate.

8 d cells form syncytia that express chorionic gonadotrophin (CG).

9 tuitarism in humans that is characterized by gonadotrophin deficiency known as hypogonadotrophic hypo

10 ACTH) deficiency, and 1 had combined GH/ACTH/gonadotrophin deficiency.

11 ack of expression in hypophysectomized mice, gonadotrophin-deficient hypogonadal (hpg) mutant mice, a

12 chytene spermatocyte that is under increased gonadotrophin drive because of testicular atrophy induci

13 ne (alpha-fetoprotein and/or human chorionic gonadotrophin) during the first two cycles of chemothera

14 sites and is part of the clinically relevant gonadotrophin family.

15 s, with up-regulation and down-regulation of gonadotrophin gene expression during the breeding and no

16 Using primers specific for human chorionic gonadotrophin gene, the presence of human DNA was confir

17 h-affinity binding of LH and human chorionic gonadotrophin (hCG) causes secondary hormone or receptor

18 alpha-fetoprotein (AFP) and human chorionic gonadotrophin (HCG) during the first two cycles of chemo

19 Human chorionic gonadotrophin (hCG) is largely used to confirm pregnancy

20 rying to conceive or until a human chorionic gonadotrophin (hCG) test confirmed pregnancy.

21 e alpha and beta subunits of human chorionic gonadotrophin (hCG), a hormone essential to modulate mat

22 ractions between an antigen, human chorionic gonadotrophin (hCG), and antibodies, anti-alpha-hCG and

23 e pretreatment level of HCG; human chorionic gonadotrophin (HCG; < or = 100 times the upper limit of

24 ded by alpha-fetoprotein and human chorionic gonadotrophin in the management of germ cell tumor (GCT)

25 RH) receptors and the second after 9 days of gonadotrophin injections.

26 Ca-125 level, 15 U/mL; beta-human chorionic gonadotrophin level < 2 IU/mL).

27 The effects of gonadotrophins like prolactin are discussed as stimulant

28 The importance of accurate human chorionic gonadotrophin monitoring and the types of human chorioni

29 rone free LPS, intramuscular human chorionic gonadotrophin, [OR 9.67 (95% CrI 2.34, 73.2)] was also f

30 n F2alpha(PGF2alpha) and pregnant mare serum gonadotrophin (PMSG).

31 monitoring and the types of human chorionic gonadotrophin produced in cancer are also topical.

32 ell line-derived recombinant human chorionic gonadotrophin (r-alpha hCG), a protein that is glycosyla

33 of VIP in the gender-specific regulation of gonadotrophin release in rats.

34 a sustained increase in pulsatile release of gonadotrophin releasing hormone (GnRH) from the hypothal

35 Cells were stimulated with either gonadotrophin releasing hormone (GnRH) or by membrane de

36 as following the downregulation of pituitary gonadotrophin releasing hormone (GnRH) receptors and the

37 ergic transmission regulates the activity of gonadotrophin-releasing hormone (GnRH) neurons in the pr

38 ously shown that central CGRP suppresses the gonadotrophin-releasing hormone (GnRH) pulse generator,

39 Gonadotrophin-releasing hormone (GnRH) regulates the mam

40 dealing with various stressors that regulate gonadotrophin-releasing hormone (GnRH) secretion in a va

41 for vasoactive intestinal peptide (VIP) and gonadotrophin-releasing hormone (GnRH) was carried out o

42 secretion is controlled by the hypothalamic gonadotrophin-releasing hormone (GnRH), and gonadal ster

43 e axis, specifically inhibition of pulsatile gonadotrophin-releasing hormone (GnRH)/luteinising hormo

44 dentified race and use of ADT defined as any gonadotrophin-releasing hormone agonist or antagonist pr

45 7 alpha-hydroxyprogesterone to leuprolide, a gonadotrophin-releasing hormone agonist, and performed o

46 logue (CEP-701), as the trk inhibitor, and a gonadotrophin-releasing hormone agonist, Leuprolide, to

47 and progesterone stimulate their growth, and gonadotrophin-releasing hormone agonists shrink them.

48 el SERMs, aromatase inhibitors/inactivators, gonadotrophin-releasing hormone agonists, retinoids, sta

49 rse ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the

50 nous reproductive hormone production using a gonadotrophin-releasing hormone antagonist (GnRHant) for

51 although reproduction relies on hypothalamic gonadotrophin-releasing hormone output, and most cells p

52 in-deficient states, leptin therapy restores gonadotrophin secretion, as well as luteinizing hormone

53 PD prolactin-producing cells known to impair gonadotrophin secretion.

54 teroids act to regulate sexual behaviour and gonadotrophin secretion.

55 o promote desensitization of human chorionic gonadotrophin-stimulated AC activity, in the presence of

56 ied beta-arrestin-1 mimicked human chorionic gonadotrophin to promote desensitization of human chorio

57 ariety of sequences, such as human chorionic gonadotrophin, ubiquitin, TFIIA, guanine nucleotide-bind

58 arkers alpha-fetoprotein and human chorionic gonadotrophin were correlated with treatment outcome as

59 l testosterone, estradiol, progesterone, and gonadotrophins, were assessed concomitantly to electroca